Good afternoon :)
Place Order
Add to Watchlist

Max Healthcare Institute Ltd

MAXHEALTH

Max Healthcare Institute Ltd

MAXHEALTH
Health CareHospitals & Diagnostic Centres
MidcapWith a market cap of ₹93,611 cr, stock is ranked 116
Moderate RiskStock is 2.84x as volatile as Nifty
952.851.05% (-10.10)
952.851.05% (-10.10)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
MidcapWith a market cap of ₹93,611 cr, stock is ranked 116
Moderate RiskStock is 2.84x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
MidcapWith a market cap of ₹93,611 cr, stock is ranked 116
Moderate RiskStock is 2.84x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
88.8311.130.16%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.236.560.48%

Forecast & Ratings

Detailed Forecast 
75%
Analysts have suggested that investors can buy this stock

from 16 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Max Healthcare is provider of home health care services including Patient Care, Healthcare Services, and Hospitals.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 27.47%, vs industry avg of 10.02%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 4.77% to 9.53%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,470.541,667.821,794.471,748.071,956.852,619.414,290.794,970.615,882.275,835.41
Raw Materialssubtract403.39423.00431.05362.20409.14580.51930.46936.881,119.044,121.83
Power & Fuel Costsubtract40.7340.9041.3646.0638.9351.3762.6769.0477.54
Employee Costsubtract304.74353.47422.91440.55449.24588.78768.95810.04937.12
Selling & Administrative Expensessubtract168.55593.95647.99630.23191.43208.86510.39631.33741.49
Operating & Other expensessubtract413.1356.6172.5756.80506.63904.99957.431,143.551,336.89
Depreciation/Amortizationsubtract91.2195.5194.42102.64119.74174.09221.12232.19244.98266.06
Interest & Other Itemssubtract67.7599.6899.37101.27152.66179.46100.8783.8659.8964.38
Taxes & Other Itemssubtract3.65-11.099.9511.33-6.2668.90133.85-39.79307.68329.31
EPS-0.440.29-0.47-0.061.77-1.836.2511.3710.8910.84
DPS0.000.000.000.000.000.000.001.001.501.00
Payout ratio0.000.000.000.000.000.000.000.090.140.09

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

May 31PDF
Aug 21PDF
FY 2022

Annual report

PDF

Investor Presentation

Feb 7PDF
Nov 15PDF
FY 2023

Annual report

PDF

Investor Presentation

Feb 2PDF
Nov 8PDF
Nov 1PDF
Aug 10PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 21PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Max Healthcare Institute Ltd88.5111.130.16%
Apollo Hospitals Enterprise Ltd112.5813.820.23%
Fortis Healthcare Ltd74.755.230.17%
Global Health Ltd82.9510.51

Price Comparison

Compare MAXHEALTH with any stock or ETF
Compare MAXHEALTH with any stock or ETF
MAXHEALTH
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding23.74%12.19%3.18%56.98%3.91%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun51.95%59.89%60.38%60.69%57.33%56.98%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Max Healthcare Institute Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
HDFC Mid-Cap Opportunities Fund - Growth - Direct Plan

Growth
2.0946%2.60%-0.43%13/76 (-6)
SBI Equity Hybrid Fund - Growth - Direct Plan

Growth
0.7278%0.93%-0.11%25/90 (-3)
Canara Robeco Emerging Equities - Growth - Direct Plan

Growth
0.5989%2.24%-0.41%9/85 (-2)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 23, 2024

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Aug 23, 2024

Cash Dividend

Ex DateEx DateSep 8, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 8, 2023

News & Opinions
Corporate
Max Healthcare Institute allots 2.06 lakh equity shares under ESOS

Max Healthcare Institute has allotted 2,06,091 equity shares under ESOS on 13 September 2024. With this allotment, the paid up equity share capital has increased to 97,21,32,053 equity shares of Rs 10 each. Powered by Capital Market - Live

5 days agoCapital Market - Live
Corporate
Outcome of board meeting of Max Healthcare Institute

The Board of Max Healthcare Institute at its meeting held on 13 September 2024 has approved execution of strategic collaboration agreement with Lakshdeep Investments and Finance and Lakshdeep Infrastructure and Holdings (collectively referred to as 'Lakshdeep Group'). Lakshdeep Group entities are indirect holding companies of Jaypee Healthcare ('JHL') who have been permitted to work out / submit a viable plan/solution in relation to the revival of JHL vide order dated 11 July 2024 of Hon'ble National Company Law Appellate Tribunal ('NCLAT'), Delhi. The NCLAT has approved the settlement agreed to between Lakhsdeep Group and the Committee of Creditors of JHL ('CoC') vide its order dated 12 September 2024. The Company, as strategic partner under the aforesaid arrangement, shall enter into an agreement to acquire ~64% equity stake of JHL within 30 days of NCLAT order. The Company proposes to enter into option agreement for acquisition of remaining ~36% equity stake. The Board has also approved raising of funds by way of short term loans at the Company level up to Rs 1,000 Crore for settlement of admitted claims of the financial creditor of JHL and utilization of internal accruals of the Company for the proposed purchase of equity shares of JHL. Further, the Company shall also organize loan at JHL level for the repayment of its short term debt.In this regard, the Board has also approved issuance of corporate guarantee to the bank/ financial institution for loan proposed to be extended to JHL. Powered by Capital Market - Live

5 days agoCapital Market - Live
Corporate
Max Healthcare Institute inks deal to acquire controlling stake in Jaypee Healthcare

Max Healthcare Institute (MHIL) has entered into a Strategic Collaboration Agreement with Lakshdeep Group, the ultimate promoter group of Jaypee Healthcare (JHL) - which is undergoing Corporate Insolvency Resolution Process (CIRP). This Strategic Collaboration and proposed acquisition will give MHIL a controlling stake in JHL, including its flagship asset, the renowned 500-beds Jaypee Hospital, Noida. Under the agreement, MHIL shall organize debt for repayment of admitted claims of the financial creditors of JHL and proposes to simultaneously acquire ~64% stake in the company, with call and put option for the remaining stake. The acquisition is based on an enterprise value of Rs 1,660 crore, reflecting JHL's strong market position, which includes two operational hospitals i.e. 500-bedsJaypee Hospital, Noida and 200-beds Jaypee Hospital Bulandshahr, built on land parcel of 18 acre and 5.75 acre respectively. Further JHL also owns a 100-beds hospital spread over 2.35 acres at Anoopshahar, which is currently non-operational. JHL reported revenue of Rs 421 crore and EBITDA of Rs 70 crore for the year 2023-24. The transaction, which includes the Strategic Collaboration Agreement and the acquisition of JHL's stake held by financial creditors, shall be consummated in next thirty days in line with the revival plan approved by the Hon'ble National Company Law Appellate Tribunal (NCLAT). The revival plan is designed to provide sustainability to the operations of Jaypee Hospitals through appropriate measures to enhance operational efficiency while building confidence among various stakeholders. With the proposed transaction and collaboration with Max Healthcare as strategic partner to the revival plan, JHL is well positioned for potential growth and continued services to the community.Powered by Capital Market - Live

5 days agoCapital Market - Live
Corporate
Max Healthcare Institute to conduct AGM

Max Healthcare Institute announced that the 23th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live

Max Healthcare shares down 0.28% as Sensex rises

1 month agoEconomic Times

Buy Max Healthcare Institute, target price Rs 975: Prabhudas Lilladher

1 month agoEconomic Times

Buy Max Healthcare Institute, target price Rs 1055: Motilal Oswal

1 month agoEconomic Times

Max Healthcare Institute consolidated net profit declines 1.59% in the June 2024 quarter

1 month agoBusiness Standard
Earnings
Max Healthcare Institute consolidated net profit declines 1.59% in the June 2024 quarter

Net profit of Max Healthcare Institute declined 1.59% to Rs 236.27 crore in the quarter ended June 2024 as against Rs 240.08 crore during the previous quarter ended June 2023. Sales rose 20.07% to Rs 1542.95 crore in the quarter ended June 2024 as against Rs 1284.99 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1542.951284.99 20 OPM %25.1126.26 - PBDT398.21359.31 11 PBT321.31303.49 6 NP236.27240.08 -2 Powered by Capital Market - Live

1 month agoCapital Market - Live
Max Healthcare Q1 Post Strategy: कंपनी के नतीजों पर मैनेजमेंट से चर्चा,कहां और कितना बिजनेस Expand?
1 month agoCNBC Awaaz.